Table 1.
Participant characteristics of National Stakeholder Meeting
Characteristic | n/total N (%) |
---|---|
Age category, yr | |
20–29 | 4/45 (9%) |
30–39 | 12/45 (27%) |
40–49 | 15/45 (33%) |
50–59 | 10/45 (22%) |
60–69 | 4/45 (9%) |
Sex | |
Female | 25/45 (56%) |
Ethnic origin* | |
North American | 26/45 (58%) |
British Isles | 12/45 (27%) |
Western European | 9/45 (20%) |
East and Southeast Asian | 4/45 (9%) |
South Asian | 4/45 (9%) |
Eastern European | 2/45 (4%) |
Northern European | 1/45 (2%) |
Indigenous | 1/45 (2%) |
Prefer not to answer | 0/45 (0%) |
Southern European | 0/45 (0%) |
Latin, Central, and South American | 0/45 (0%) |
Ocean and Pacific Islands | 1/45 (2%) |
Province | |
British Columbia | 1/45 (2%) |
Alberta | 20/45 (44%) |
Saskatchewan | 3/45 (7%) |
Manitoba | 2/45 (4%) |
Ontario | 12/45 (27%) |
Quebec | 3/45 (7%) |
Nova Scotia | 2/45 (4%) |
New Brunswick | 0/45 (0%) |
Newfoundland & Labrador | 0/45 (0%) |
Prince Edward Island | 1/45 (2%) |
Territories (Northwest Territories, Nunavut, and Yukon) | 1/45 (2%) |
Stakeholder group* | |
Patient1 | 3/45 (7%) |
Family members2 | 2/45 (4%) |
Nurse | 9/45 (20%) |
Physician | 20/45 (47%) |
Researcher | 8/45 (18%) |
Respiratory therapist | 5/45 (11%) |
Social worker | 1/45 (2%) |
Physiotherapist | 3/45 (7%) |
Decision-maker3 | 8/45 (18%) |
*Participants self-selected their stakeholder group. As such, responses are not mutually exclusive and add up to more than 100%.
1None were hospitalized for COVID-19
2None were family members of patients hospitalized for COVID-19
3Decision-makers included a program director, a provincial clinical services lead, a health zone manager, an administrator of a network of teaching hospitals, a unit manager, a medical director, a research manager, a research chair in pandemic preparedness, and a health authority provincial medical director of pandemic critical care